Med-IQ
Decreasing the Burden of Type 2 Diabetes Mellitus
Print Publication Print Publication

Decreasing the Burden of Type 2 Diabetes Mellitus


Developed in collaboration:
UAMSMed-IQ

Time to Complete:
1 hour
Released:
12/23/16
Expires:
12/22/17

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)
1.0 Accreditation Council for Pharmacy Education (ACPE)
1.0 American Nurses Credentialing Center (ANCC)
By clicking "Read," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Print Publication Print Publication
By clicking "Read," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
1 hour

Released:
12/23/16

Expires:
12/22/17

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
1.0 Accreditation Council for Pharmacy Education (ACPE)
1.0 American Nurses Credentialing Center (ANCC)
Share on:
Print Publication Print Publication
By clicking "Read," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
1 hour
Released:
12/23/16
Expires:
12/22/17


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
1.0 Accreditation Council for Pharmacy Education (ACPE)
1.0 American Nurses Credentialing Center (ANCC)


Overview: This continuing medical education publication reviews screening and treatment recommendations for the evidence-based management of patients with type 2 diabetes. It also discusses individualizing glycemic targets and treatments to optimally control hyperglycemia based on patient-, treatment-, and disease-related factors. Appropriate surveillance and treatment of diabetes-related sequelae are also explored.

Faculty

Donald Bodenner, MD, PhD

Professor of Geriatrics

Director of the Thyroid Center

Chief of Endocrine Oncology

University of Arkansas for Medical Sciences, COM

Little Rock, AR

Marcia Byers, PhD, RN

Director of Research

Regional Programs

University of Arkansas for Medical Sciences

Little Rock, AR

Mark Jansen, MD

University of Arkansas for Medical Sciences

Associate Professor, Department of Family and Preventive Medicine

Medical Director of UAMS Regional Programs

Arkansas Blue Cross and Blue Shield George K. Mitchell, M.D. Endowed Chair in Primary Care

Little Rock, AR

Elvin Price, PharmD, PhD

Assistant Professor of Pharmaceutical Sciences

College of Pharmacy

University of Arkansas for Medical Sciences

Little Rock, AR


Disclosure Policy

UAMS Office of Continuing Education and Med-IQ require any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. UAMS Office of Continuing Education and Med-IQ have policies in place that will identify and resolve COIs prior to this educational activity. UAMS Office of Continuing Education and Med-IQ also require faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Donald Bodenner, MD, PhD, has indicated no real or apparent conflicts.

Marcia Byers, PhD, RN, has indicated no real or apparent conflicts.

Mark Jansen, MD, has indicated no real or apparent conflicts.

Elvin Price, PharmD, PhD, has indicated no real or apparent conflicts.

Katherine Stevens-Favorite, PhD
Consulting Fees: Leading Bio Sciences

The peer reviewers and other activity planners have no financial relationships to disclose.

This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by educational grants from Novo Nordisk and Sanofi US.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.